Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases
characterized by the formation of extracellular amyloid beta (Aβ) plaques and intracellular …

Alzheimer's disease is a progressive neurodegenerative disease, and its incidence is
expected to increase owing to the aging population worldwide. Current therapies merely …

This study examines the link between peripheral immune changes in perpetuation of the
Alzheimer's disease (AD) neuropathology and cognitive deficits. Our research design using …

Alzheimer's disease (AD) is associated with dysregulated immune and inflammatory
responses. Emerging evidence indicates that peripheral immune activation is linked to …

Alzheimer's disease (AD) represents the most common type of neurodegenerative dementia
and is characterized by extracellular amyloid-β (Aβ) deposition, pathologic intracellular tau …

Background The immune system plays a major role in the pathogenesis of age-related
dementia, including Alzheimer's disease (AD). An insight into age-associated changes in the …

Background: Alzheimer's disease (AD) is associated with age-associated central nervous
system degeneration and dementia. This decline in the function correlates with deposition of …

Epidemiologic studies suggest that we are on the precipice of a worldwide epidemic of
Alzheimer's disease (AD), yet current treatment options are limited to short term symptomatic …

Intravenous immunoglobulin (IVIg) preparations are being investigated as a potential agent
for treatment or prevention of Alzheimer's disease (AD). Antibodies towards soluble β …

Introduction We present safety results from a study of Gammagard Liquid intravenous
immunoglobulin (IGIV) in patients with probable Alzheimer's disease. Methods This was a …